vs

Side-by-side financial comparison of HARTE HANKS INC (HHS) and NATURAL ALTERNATIVES INTERNATIONAL INC (NAII). Click either name above to swap in a different company.

HARTE HANKS INC is the larger business by last-quarter revenue ($39.9M vs $34.8M, roughly 1.1× NATURAL ALTERNATIVES INTERNATIONAL INC). HARTE HANKS INC runs the higher net margin — 5.5% vs -7.3%, a 12.9% gap on every dollar of revenue. On growth, NATURAL ALTERNATIVES INTERNATIONAL INC posted the faster year-over-year revenue change (2.1% vs -15.4%). HARTE HANKS INC produced more free cash flow last quarter ($-686.0K vs $-7.3M). Over the past eight quarters, NATURAL ALTERNATIVES INTERNATIONAL INC's revenue compounded faster (17.7% CAGR vs -6.4%).

Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.

Natural Alternatives International, Inc. (NAI) is an American company based in Carlsbad, California which manufactures nutritional supplements such as Juice Plus. NAI was founded in 1980 by Mark A. LeDoux, and had 241 employees in 2007. NAI's manufacturing facilities are located in Vista, California, Switzerland and Japan.

HHS vs NAII — Head-to-Head

Bigger by revenue
HHS
HHS
1.1× larger
HHS
$39.9M
$34.8M
NAII
Growing faster (revenue YoY)
NAII
NAII
+17.5% gap
NAII
2.1%
-15.4%
HHS
Higher net margin
HHS
HHS
12.9% more per $
HHS
5.5%
-7.3%
NAII
More free cash flow
HHS
HHS
$6.6M more FCF
HHS
$-686.0K
$-7.3M
NAII
Faster 2-yr revenue CAGR
NAII
NAII
Annualised
NAII
17.7%
-6.4%
HHS

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
HHS
HHS
NAII
NAII
Revenue
$39.9M
$34.8M
Net Profit
$2.2M
$-2.6M
Gross Margin
7.2%
Operating Margin
-0.3%
-5.3%
Net Margin
5.5%
-7.3%
Revenue YoY
-15.4%
2.1%
Net Profit YoY
-16.5%
EPS (diluted)
$0.30
$-0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HHS
HHS
NAII
NAII
Q4 25
$39.9M
$34.8M
Q3 25
$39.5M
$37.7M
Q2 25
$38.6M
$33.9M
Q1 25
$41.6M
$28.8M
Q4 24
$47.1M
$34.1M
Q3 24
$47.6M
$33.1M
Q2 24
$45.0M
$29.5M
Q1 24
$45.4M
$25.1M
Net Profit
HHS
HHS
NAII
NAII
Q4 25
$2.2M
$-2.6M
Q3 25
$-2.3M
$-291.0K
Q2 25
$-335.0K
$-7.2M
Q1 25
$-392.0K
$-2.2M
Q4 24
$-2.2M
Q3 24
$142.0K
$-2.0M
Q2 24
$-27.8M
$-1.9M
Q1 24
$-171.0K
$-1.6M
Gross Margin
HHS
HHS
NAII
NAII
Q4 25
7.2%
Q3 25
11.7%
Q2 25
10.4%
Q1 25
6.3%
Q4 24
4.9%
Q3 24
6.8%
Q2 24
4.8%
Q1 24
7.6%
Operating Margin
HHS
HHS
NAII
NAII
Q4 25
-0.3%
-5.3%
Q3 25
1.3%
0.8%
Q2 25
0.1%
-5.7%
Q1 25
-0.1%
-7.3%
Q4 24
-3.3%
-8.2%
Q3 24
4.0%
-5.5%
Q2 24
3.0%
-8.6%
Q1 24
0.8%
-7.8%
Net Margin
HHS
HHS
NAII
NAII
Q4 25
5.5%
-7.3%
Q3 25
-5.8%
-0.8%
Q2 25
-0.9%
-21.3%
Q1 25
-0.9%
-7.6%
Q4 24
-6.4%
Q3 24
0.3%
-6.0%
Q2 24
-61.8%
-6.4%
Q1 24
-0.4%
-6.3%
EPS (diluted)
HHS
HHS
NAII
NAII
Q4 25
$0.30
$-0.42
Q3 25
$-0.31
$-0.05
Q2 25
$-0.05
$-1.21
Q1 25
$-0.05
$-0.37
Q4 24
$-0.31
$-0.37
Q3 24
$0.02
$-0.33
Q2 24
$-3.84
$-0.32
Q1 24
$-0.02
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HHS
HHS
NAII
NAII
Cash + ST InvestmentsLiquidity on hand
$5.6M
$3.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$20.5M
$67.0M
Total Assets
$91.8M
$153.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HHS
HHS
NAII
NAII
Q4 25
$5.6M
$3.8M
Q3 25
$6.5M
$7.7M
Q2 25
$4.8M
$12.3M
Q1 25
$9.0M
$10.6M
Q4 24
$9.8M
$8.7M
Q3 24
$5.9M
$10.2M
Q2 24
$11.0M
$12.0M
Q1 24
$11.5M
$12.4M
Stockholders' Equity
HHS
HHS
NAII
NAII
Q4 25
$20.5M
$67.0M
Q3 25
$19.9M
$69.0M
Q2 25
$22.2M
$68.4M
Q1 25
$21.4M
$76.6M
Q4 24
$21.7M
$79.1M
Q3 24
$21.0M
$80.2M
Q2 24
$20.6M
$82.6M
Q1 24
$20.0M
$84.1M
Total Assets
HHS
HHS
NAII
NAII
Q4 25
$91.8M
$153.3M
Q3 25
$92.7M
$156.9M
Q2 25
$95.0M
$151.9M
Q1 25
$100.6M
$154.9M
Q4 24
$101.8M
$156.1M
Q3 24
$108.1M
$161.3M
Q2 24
$109.7M
$162.3M
Q1 24
$113.4M
$153.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HHS
HHS
NAII
NAII
Operating Cash FlowLast quarter
$737.0K
$-6.3M
Free Cash FlowOCF − Capex
$-686.0K
$-7.3M
FCF MarginFCF / Revenue
-1.7%
-20.9%
Capex IntensityCapex / Revenue
3.6%
2.7%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$-4.5M
$-5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HHS
HHS
NAII
NAII
Q4 25
$737.0K
$-6.3M
Q3 25
$3.2M
$-4.0M
Q2 25
$-4.8M
$3.3M
Q1 25
$-818.0K
$6.0M
Q4 24
$4.0M
$37.0K
Q3 24
$-2.9M
$-3.4M
Q2 24
$1.6M
$-2.7M
Q1 24
$-5.7M
$-3.6M
Free Cash Flow
HHS
HHS
NAII
NAII
Q4 25
$-686.0K
$-7.3M
Q3 25
$2.2M
$-5.1M
Q2 25
$-5.1M
$1.9M
Q1 25
$-923.0K
$5.2M
Q4 24
$3.4M
$-1.0M
Q3 24
$-4.9M
$-3.7M
Q2 24
$926.0K
$-3.8M
Q1 24
$-6.2M
$-3.9M
FCF Margin
HHS
HHS
NAII
NAII
Q4 25
-1.7%
-20.9%
Q3 25
5.5%
-13.4%
Q2 25
-13.1%
5.6%
Q1 25
-2.2%
18.0%
Q4 24
7.3%
-3.0%
Q3 24
-10.2%
-11.3%
Q2 24
2.1%
-12.7%
Q1 24
-13.7%
-15.5%
Capex Intensity
HHS
HHS
NAII
NAII
Q4 25
3.6%
2.7%
Q3 25
2.5%
2.7%
Q2 25
0.6%
4.3%
Q1 25
0.3%
2.8%
Q4 24
1.3%
3.1%
Q3 24
4.0%
0.9%
Q2 24
1.5%
3.5%
Q1 24
1.2%
1.1%
Cash Conversion
HHS
HHS
NAII
NAII
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-20.76×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HHS
HHS

Fulfillment And Logistics Services$17.3M43%
Customer Care$13.7M34%
Other$8.9M22%

NAII
NAII

Private Label Contract Manufacturing$32.8M94%
Patent And Trademark Licensing$2.0M6%

Related Comparisons